# Low-dose VS High-dose IV Cyclophosphamide for Proliferative LN in Children

> **NCT01861561** · PHASE4 · TERMINATED · sponsor: **Mahidol University** · enrollment: 43 (actual)

## Conditions studied

- Renal Insufficiency
- Infection

## Interventions

- **DRUG:** Low-dose intravenous cyclophosphamide
- **DRUG:** High-dose intravenous cyclophosphamide

## Key facts

- **NCT ID:** NCT01861561
- **Lead sponsor:** Mahidol University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-05
- **Primary completion:** 2019-05
- **Final completion:** 2019-05
- **Target enrollment:** 43 (ACTUAL)
- **Why stopped:** The duration of the study is longer than 5 years and we can not recruit the participants to the target number.
- **Last updated:** 2020-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01861561

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01861561, "Low-dose VS High-dose IV Cyclophosphamide for Proliferative LN in Children". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01861561. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*